高血压性脑出血患者血清ITIH4、CIRP、NINJ1水平变化及与神经功能缺损和预后的关系OA
Changes in serum levels of ITIH4,CIRP and NINJ1 in patients with hypertensive intracerebral hemorrhage and their relationship with neurological deficits and prognosis
目的 探讨高血压性脑出血(HICH)患者血清间α胰蛋白酶抑制因子重链H4(ITIH4)、冷诱导RNA结合蛋白(CIRP)、神经损伤诱导蛋白1(NINJ1)水平变化及其与神经功能缺损和预后的关系.方法 选取2022年1月至2024年1月期间在邯郸市第一医院收治的HICH患者191例为研究对象,均行微创颅内血肿穿刺引流术;依据美国国立卫生研究院卒中量表(NIHSS)评分将患者分为轻度缺损组63例,中度缺损组71例,重度缺损组57例,并根据患者出院后6个月的预后情况分为预后良好组 108 例和预后不良组 83 例.ELISA 法检测血清 ITIH4、CIRP、NINJ1水平;采用 Pearson 法分析血清 ITIH4、CIRP、NINJ1 水平与 NIHSS 评分的相关性;多因素Logistic 回归分析影响 HICH 患者预后不良的因素;ROC 曲线分析血清 ITIH4、CIRP、NINJ1 水平对 HICH 患者预后不良的预测价值.结果 HICH 患者血清 ITIH4 水平呈现神经功能重度缺损组低于中度缺损组和轻度缺损组,血清CIRP、NINJ1 水平均呈现重度缺损组高于中度缺损组和轻度缺损组(P<0.05);血清ITIH4 水平与NIHSS 评分呈负相关(r=-0.524,P<0.05),血清CIRP、NINJ1 水平与 NIHSS 评分呈正相关(r=0.351、0.403,P<0.05);预后不良组血清 ITIH4 水平以及术前格拉斯哥昏迷量表(GCS)评分低于预后良好组,术中出血量≥50 mL 占比、血肿清除率<80ᆪ占比、破入脑室占比、血清 CIRP、NINJ1 水平高于预后良好组,差异有统计学意义(P<0.05);术中出血量、血肿清除率、破入脑室、术前GCS评分以及血清ITIH4、CIRP、NINJ1是HICH患者预后不良的影响因素(OR=1.549、1.695、1.916、1.352、0.637、2.917、3.265,P<0.05);血清ITIH4、CIRP、NINJ1联合预测HICH患者预后不良的AUC为0.937,优于各自单独预测(Z=3.695、3.385、3.210,P<0.05).结论 HICH患者血清ITIH4、CIRP、NINJ1水平变化与神经功能缺损和预后均有关,三者联合检测对预测HICH患者预后不良具有较好的临床应用价值.
Objective To investigate the changes in serum levels of inter-alpha-trypsin inhibitor heavy chain H4(ITIH4),cold-inducible RNA-binding protein(CIRP),and nerve injury-induced protein 1(NINJ1)in patients with hypertensive intracerebral hemorrhage(HICH),and their relationship with neurological deficits and prognosis.Methods A total of 191 HICH patients admitted to Handan First Hospital between January 2022 and January 2024 were selected as the study subjects,all of whom underwent minimally invasive intracranial hematoma puncture and drainage.According to the National Institutes of Health Stroke Scale(NIHSS)scores,patients were assigned to a mild deficit group of 63 cases,a moderate deficit group of 71 cases,and a severe deficit group of 57 cases.Based on the 6-month post-discharge prognosis,they were assigned into a good prognosis group 108 cases and a poor prognosis group 83 cases.ELISA was applied to detect serum levels of ITIH4,CIRP,and NINJ1.Pearson correlation analysis was applied to assess the correlation between serum ITIH4,CIRP,NINJ1 levels and NIHSS scores.Multivariate Logistic regression was applied to analyze factors affecting the poor prognosis in HICH patients.ROC curve was applied to analyze the predictive value of serum ITIH4,CIRP,and NINJ1 levels for poor prognosis in HICH patients.Results Serum ITIH4 level in HICH patients was lower in the severe neurological deficit group than in the moderate and mild deficit groups,while serum CIRP and NINJ1 levels were higher in the severe deficit group compared to the moderate and mild deficit groups(P<0.05).Serum ITIH4 level was negatively correlated with NIHSS score(r=-0.524,P<0.05),whereas serum CIRP and NINJ1 levels were positively correlated with NIHSS scores(r=0.351,0.403;P<0.05).Compared with the good prognosis group,the poor prognosis group had lower serum ITIH4 level and higher proportions of intraoperative hemorrhage≥50 mL,hematoma clearance rate<80ᆪ,and intraventricular extension,as well as higher preoperative Glasgow Coma Scale(GCS)scores and serum CIRP and NINJ1 levels,with statistically significant differences(P<0.05).Intraoperative hemorrhage,hematoma clearance rate,intraventricular extension,preoperative GCS score,and serum levels of ITIH4,CIRP,and NINJ1 were identified as influencing factors for the poor prognosis in HICH patients(OR=1.549,1.695,1.916,1.352,0.637,2.917,3.265,respectively;P<0.05).The combined predictive value of serum ITIH4,CIRP,and NINJ1 levels for the poor prognosis in HICH patients yielded an area under the ROC curve(AUC)of 0.937,which was superior to the predictive performance of each biomarker alone(Z=3.695,3.385,3.210,respectively;P<0.05).Conclusion Changes in serum levels of ITIH4,CIRP,and NINJ1 in HICH patients are related to neurological deficits and prognosis.The combined detection of three biomarkers has clinical significance in predicting poor prognosis in HICH patients.
张俊江;冯婷;刘延平;刘宁娜;康梦月
056000 河北省邯郸市第一医院神外一科056000 河北省邯郸市第一医院老年一科056000 河北省邯郸市第一医院神外一科056000 河北省邯郸市第一医院神外一科056000 河北省邯郸市第一医院神外一科
高血压性脑出血间α胰蛋白酶抑制因子重链H4冷诱导RNA结合蛋白神经损伤诱导蛋白1神经功能缺损
Hypertensive intracerebral hemorrhageInter-alpha-trypsin inhibitor heavy chain H4Cold-inducible RNA-binding proteinNerve injury-induced protein 1Neurological deficits
《心脑血管病防治》 2026 (7)
34-39,6
评论